KOMBINACIJA ANTI-KIR ANTITELA I ANTI-PD-1 ANTITELA U LEČENJU KANCERA

• 收藏
• 分享

专利权人:

BRISTOL-MYERS SQUIBB COMPANY

发明人:

GRAZIANO, ROBERT, F.,GUPTA, ASHOK, K.,KIM, SU, YOUNG,WIGGINTON, JON

申请号：

RSP20171194

公开号：

RS56624B1

申请日:

2013.10.02

申请国别(地区):

RS

年份:

2018

代理人:

摘要：

Provided herein are an anti-KIR antibody and an antibody that is selected from anti-PD-1 antibodies, anti-PD-L1 antibodies and anti-PD-L2 antibodies for use in treating cancer (e.g., advanced refractory solid tumors or hematological malignancies).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/